Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Just in
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Craigbadon Jun 29, 2016 10:03am
118 Views
Post# 25008150

RE:Just in

RE:Just inThey must be selling at half price. Merus only pays 5-6 x ebitda for assets and Cxr paid double that. Not a good sign.

peter75 wrote: Cxr is selling a piece of pharma to merus labs in england
sems the buyers don't want all of England 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities